col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


73 Ergebisse       Seite 1

 [1] 
Elsevier: Clinical Infection in Practice
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―03 15 Divergent performance of bivalent BA.5 and monovalent XBB.1.5 COVID-19 vaccines given as annual booster Marianne Shawe-taylor, David Greenwood, Agnieszka Hobbs, Giulia Dowgier, Rebecca Penn, Theo Sanderson, et al. (+13)
2 [GO] 2025―Apr―03 72 Epidemiology of pre and post COVID-19 pandemic invasive Candida infections and biomarker and antifungal use in a United Kingdom tertiary hospital Delia Mercedes Bianco, Nathan Blott, Delia Mercedes Bianco
3 [GO] 2025―Apr―03 24 B cell depletion therapy in people with Multiple Sclerosis impacts on antibody response to COVID-19 mRNA vaccines Marianne Shawe-taylor, David Greenwood, Anna He, Agnieszka Hobbs, Giulia Dowgier, Rebecca Penn, et al. (+20)
4 [GO] 2025―Jan―29 Human Metapneumovirus - A Clickbait clickbait or a real pandemic Threat? Manali Verma, Anil Kumar, Shubham Kumar, Rachana Mehta, Ranjana Sah, Amogh Verma
5 [GO] 2024―Okt―21 Mpox 2024: New variant, new challenges, and the looming pandemic Amogh Verma, Mahalaqua Nazli Khatib, Guru Datt Sharma, Mahendra Pratap Singh, Ganesh Bushi, Suhas Ballal, et al. (+4)
6 [GO] 2024―Jan―25 WHO-classified COVID-19 'variant of interest' JN.1: A community health concern in the winter and festive season Ranjan K. Mohapatra, L.V. Simhachalam Kutikuppala, Snehasish Mishra, Ashish K. Sarangi, Lawrence Sena Tuglo
7 [GO] 2024―Jan―07 The SARS-CoV-2 BA.2.86 Subvariant: A New Challenge in the Ongoing Pandemic Prakasini Satapathy, Ahmad Neyazi, Abdul Qadir Qader, Ali A. Rabaan, Nawal A. Al Kaabi, Mahalaqua Nazli Khatib, et al. (+2)
8 [GO] 2023―Dez―20 37 Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals or no treatment in England: A retrospective cohort study Vishal Patel, Marcus J. Yarwood, Bethany Levick, Daniel C. Gibbons, Myriam Drysdale, William Kerr, et al. (+7)
9 [GO] 2023―Dez―20 34 COVID-19 caused by either Omicron sub-variants or Delta in non-hospitalised adults associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination history Hermaleigh Townsley, Joshua Gahir, Timothy W. Russell, Edward J. Carr, Matala Dyke, Lorin Adams, et al. (+30)
10 [GO] 2023―Dez―20 20 Impact of COVID-19 Infection Prevention and Control (IPC) restrictions on cardiac arrest (CA) survival rates in pre-hospital practice: A scoping review Cormac Sertutxa
11 [GO] 2023―Dez―20 12 The Oxford - AstraZeneca COVID-19 vaccine: Breakthrough science and collaborative partnership Shethah Morgan, Justin Green, Andrew Pollard
12 [GO] 2023―Dez―20 65 Administration of Covid-19 vaccines to patients with a high risk of anaphylaxis- update from the NHS Lothian monitored vaccine clinic Karla Berry, Aisling Barry, Pauline Bell, Rebecca K Sutherland
13 [GO] 2023―Dez―20 33 Fourth dose bivalent mRNA vaccines containing BA.1 significantly augment neutralising antibody titres against SARS-COV-2 Omicron sub-lineages XBB and BQ.1.1 in healthy adults Mary Wu, Edward Carr, Ruth Harvey, Joshua Gahir, Hermaleigh Townsley, Guilia Dowgier, et al. (+27)
14 [GO] 2023―Dez―20 41 Generation of a SARS-CoV-2 pseudotyped viral particle system enabling for the study of cell-types of infection and patient sera neutralisation Abdullateef Alshehri, Bill Paxton, Georgios Pollakis, Jordan Thomas, Kelly Roper, Wejdan Albalawi
15 [GO] 2023―Dez―20 67 Bridging the gap: Linking early post-vaccine events to reactogenicity and later immune responses after viral-vectored and mRNA-based SARS-CoV-2 vaccines Ali Amini, Lucy Garner, Sandra Adele, Eloise Phillips, Tom Malone, Wanwisa Dejnirattisai, et al. (+8)
16 [GO] 2023―Dez―20 72 Lyme disease in Scotland 2018-2022: Pandemic effects? Mairi Cullen, Sally Mavin, Chin Lim
17 [GO] 2023―Dez―13 Antineutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis following COVID-19 BBIBP-CorV vaccine: a case report Parisa Javadian, Negin Fadaei-Tirani, Zainab Amoosoltani-Forooshani, Vahid Reisi-Vanani, Mina Borran
18 [GO] 2023―Okt―27 Multiorgan failure from excessive polypharmacy self-medication with prescription and non-prescription drugs following SARS-CoV-2 infection: a case report Kimberly Davis, Laura Ghiggino, Neda Hasan, Elaine Armstrong, Bridget L. Atkins
19 [GO] 2023―Okt―18 Clinically significant Herpes simplex virus-1 respiratory infection in ventilated COVID-19 patients - a case series Elizabeth Parker, Bethany Sharp, Martin Beed, James Bonnington, Louise Berry
20 [GO] 2023―Okt―13 Necrotizing pneumonia after COVID-19 infection due to Panton-Valentine Leucocidin-producing, methicillin-susceptible Staphylococcus aureus Joyce van Eck, Sharon Bak, Emma de Jong, Debby Vriens, Peter van Wijngaarden
21 [GO] 2023―Sep―09 SECONDARY EOSINOPHILIA A RISK FACTOR FOR PROLONGED HOSPITALIZATION IN SEVERE COVID-19: A CASE CONTROL STUDY Mark Reed, Ana Wilden, Zachary M. Holliday
22 [GO] 2023―Sep―03 Feasibility and safety of oxygen saturation remote monitoring in COVID-19: a descriptive research Jacopo Simonetti, Francesco Lombardi, Claudia Franciosa, Marta Viscuso, Luca Richeldi
23 [GO] 2023―Aug―26 The reduced incidence of respiratory viral infections in transplant recipients during the COVID-19 pandemic - a retrospective observational cross-sectional analysis of admissions to a tertiary haematology unit Hamzah Z Farooq, Shahid Iqbal, Emma Davies, Eleni Tholouli, Nicholas Machin, Fiona L. Dignan
24 [GO] 2023―Mai―23 The reactivation of herpesviruses in severe COVID-19; a retrospective analysis of a critical care cohort David Moynan, Rizwan Barkat, Ms Gordana Avramovic, Deirdre Morley, Brendan O'Kelly, John S Lambert
25 [GO] 2023―Mai―06 Treatment of COVID-19 symptoms with Over the Counter (OTC) medicines used for treatment of common cold and flu Ronald Eccles, Guy Boivin, Benjamin J Cowling, Andrew Pavia, Rangaraj Selvarangan
26 [GO] 2023―Mai―04 Impact of Common Comorbidities on Antimicrobial Consumption and Mortality amongst Critically Ill COVID-19 Patients: A Retrospective Two Center Study in Saudi Arabia Nada AlQadheeb, Hanine AlMubayedh, Sarah AlBadrani, Abdul Salam, Mukhtar AlOmar, Ahmed AlAswad, et al. (+3)
27 [GO] 2023―Apr―29 A ‘train the trainers’ approach to infection prevention and control training in pandemic conditions Kathryn A. Haigh, Francesca Liuzzi, Sharon Irvine, Alison Thompson, Edward Hepworth, Marie-Claire Hoyle, et al. (+3)
28 [GO] 2023―Mrz―31 Prescribing in a pandemic: Electronic prescribing aids to improve non-specialist adherence to COVID-19 guidelines Marc Woodman, Jo Salkeld, Connor Sharrock, C Alice Oborne, Hanna Nguyen, Alka Sobti, Anna L Goodman
29 [GO] 2023―Feb―02 Plague outbreak in Madagascar amidst COVID-19: A re-emerging concern of public health Sapna Negi, Snehasish Tripathy, Prakasini Satapathy, Ahmad Neyazi, Bijaya Kumar Padhi
30 [GO] 2023―Jan―18 Fetal demise and SARS-CoV-2 infection during pregnancy: Histopathological and immunohistochemical findings of three cases referred to the Colombian National Institute of Health Marcela Daza, Sheryll Corchuelo, Johana Osorio, Luis Alberto Gómez, Edgar Parra, Ángela Alarcón, Marcela Mercado
31 [GO] 2023―Jan―18 Cavitary lung lesion as sequelae of mild COVID-19 in a patient with HIV Carl Tanba, Ruba Habib, Terina Chen, Nahar Saleh
32 [GO] 2022―Dez―13 Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma Marissa-Skye Goldwater, Samuel D. Stampfer, Bernard Sean Regidor, Sean Bujarski, Scott Jew, Haiming Chen, et al. (+4)
33 [GO] 2022―Nov―16 Persistent SARS-CoV-2 infection in immunocompromised patients facilitates rapid viral evolution: Retrospective cohort study and literature review David Hettle, Stephanie Hutchings, Peter Muir, Ed Moran
34 [GO] 2022―Okt―13 Use of remdesivir for COVID-19 pneumonia in patients with advanced kidney disease: A retrospective multicenter study F. Stancampiano, N. Jhawar, W. Alsafi, J. Valery, D.M. Harris, P. Kempaiah, et al. (+4)
35 [GO] 2022―Okt―05 Thrombocytopenia and pneumonitis associated with BNT16B2b2 mRNA COVID-19 vaccine: A case report Yuichi Kojima, Kimihiro Takeyabu, Miki Satoh, Satoshi Konno
36 [GO] 2022―Sep―13 28 Experiences of using Paxlovid to treat clinically extremely vulnerable non-hospitalised patients with COVID-19 Joshua Gahir, Jasjot Saund, Michael Brown, Jatinder Harchowal, Laura Waters
37 [GO] 2022―Sep―13 17 COVID-19 vaccine hesitancy among a UK cohort of patients living with HIV Huw Lewis, Julia Greig, James Meiring
38 [GO] 2022―Sep―13 36 Misdiagnoses in the context of suspected pandemic influenza or COVID-19: A systematic review Lucy Bray, Katerina Meznikova, Daniel James, Pavan Mason, Razan Rislan, Rahul Shah, et al. (+4)
39 [GO] 2022―Sep―13 12 Exhaled SARS-CoV-2 viral load kinetics measured by facemask sampling and its association with household transmission - a longitudinal cohort study Daniel Pan, Caroline Williams, Jonathan Decker, Eve Fletcher, Shirley Sze, Sara Assadi, et al. (+6)
40 [GO] 2022―Jul―29 Severe coronavirus disease 2019 in a patient with TAFRO syndrome: A case report Kengo Oshima, Hajime Kanamori, Kentarou Takei, Hiroaki Baba, Koichi Tokuda
41 [GO] 2022―Jul―07 The COVID-19 pandemic management strategies and the acute severe hepatitis outbreak of unknown origin in children Aurelio Tobías, Josep María García-Alamino, Pau Fonseca i Casas, Raül Tormos
42 [GO] 2022―Mai―12 Safety and Efficacy of Favipiravir for the management of COVID-19 Patients: A Randomized Control Trial S.M. Abdur Rahman, Ahmedul Kabir, ABM Abdullah, Md Billal Alam, Khan Abul Kalam Azad, Md Titu Miah, et al. (+4)
43 [GO] 2022―Mai―12 Risk of SARS-CoV2 by vaccination status and population characteristics in Qatar Mohamed Ahmed Syed, Ahmed Sameer Al Nuaimi, Hamda Abdulla A/Qotba
44 [GO] 2022―Apr―26 Post-acute coronavirus disease 2019 (COVID 19) syndrome: Silvia Roda, Alessandra Ricciardi, Angela Maria Di Matteo, Marco Zecca, Patrizia Morbini, Marco Vecchia, et al. (+4)
45 [GO] 2022―Mrz―23 Personal protective equipment training & lived experience for healthcare staff during COVID-19 J. Cahill, A. Kay, V. Howard, B. Mulcahy, M. Forde, S. George, et al. (+4)
46 [GO] 2022―Mrz―21 Comment on ““Multi inflammatory syndrome following first dose of m-RNA COVID-19 vaccination” Pathum Sookaromdee, Viroj Wiwanitkit
47 [GO] 2022―Feb―16 Duration of viable SARS-CoV-2 shedding from respiratory tract in different human hosts and its impact on isolation discontinuation polices revision; a narrative review Mohammed Qutub, Yasser Aldabbagh, Fahtima Mehdawi, Abdullah Alraddadi, Mohanna Alhomsy, Abdulaziz Alnahdi, et al. (+4)
48 [GO] 2022―Feb―15 Higher mortality of hospitalized haematologic patients with COVID-19 compared to non-haematologic is driven by thrombotic complications and development of ARDS: An age-matched cohorts study Ana Fernández-Cruz, Alba Puyuelo, Lucía Núñez Martín-Buitrago, Enrique Sánchez-Chica, Carmen Díaz-Pedroche, Rosa Ayala, et al. (+4)
49 [GO] 2022―Feb―15 Multi inflammatory syndrome in a 16-year-old male following first dose of m-RNA COVID-19 vaccination Patrick Hugh McGann, Ahmed O.A. Krim, Jared Green, Jacqueline Venturas
50 [GO] 2022―Feb―15 COVID-19 associated pulmonary aspergillosis (CAPA) case series in NHS Greater Glasgow and Clyde (GGC) Shadin Hassan, Mairi Macleod
51 [GO] 2022―Feb―15 Urinary antigen testing for respiratory infection during COVID-19: The microbiologist as a diagnostic steward Tom Williams, Luke Blagdon Snell, Jonathan Edgeworth, Geraldine O'Hara
52 [GO] 2022―Feb―15 Clinical outcome of shielded patients who have been infected with COVID-19 in Barnsley Borough- June 2020 Dina Mahmoud, Muhalab Yousif
53 [GO] 2022―Jan―07 COVID-19 with a heavily mutated variant in a multiple myeloma after vaccination: correspondence Rujittika Mungmunpuntipantip, Viroj Wiwanitkit
54 [GO] 2022―Jan―04 Asymptomatic RT-PCR positive COVID-19 patients in orthopaedic pre-operative evaluation during the peak of the second wave Md Samiul Islam, Sultana Parvin, Mohammad Mahbubur Rahman Khan, GM Jahangir Hossain, AKM Zahiruddin, Md Jahangir Alam, et al. (+4)
55 [GO] 2021―Dez―09 Severe breakthrough COVID-19 with a heavily mutated variant in a multiple myeloma patient 10 weeks after vaccination Samuel D. Stampfer, Marissa-Skye Goldwater, Sean Bujarski, Bernard Regidor, Wenjuan Zhang, Aaron J. Feinstein, et al. (+4)
56 [GO] 2021―Dez―08 Image challenge: left sided facial swelling in a patient with COVID-19 Melissa Chowdhury, Junko Takata, Issa Beegun, Chris Burd, Taranjit Tatla, Tumena Corrah
57 [GO] 2021―Dez―06 SARS-CoV-2 related ARDS and Invasive Fungal Infections in Intensive Care Patients Darren Borg, James Farrugia, Charles Mallia Azzopardi
58 [GO] 2021―Sep―17 Hemophagocytic lymphohistiocytosis in adults: A key issue in the COVID-19 era Miguel Augusto Martins Pereira, Lygia Marina Mendes da Costa, Suelen Brito Nascimento, Hye Chung Kang, Adelmo Henrique Daumas Gabriel
59 [GO] 2021―Sep―01 Efficacy of convalescent plasma therapy in immunocompromised patients with COVID-19: A case report Genni Casarola, Marco D'Abbondanza, Rosa Curcio, Riccardo Alcidi, Tommaso Campanella, Rachele Rossi, et al. (+8)
60 [GO] 2021―Aug―21 Multisystem Inflammatory Syndrome in Adults Following COVID-19 Infection: A Case Report Presenting With Colitis Craig E McCrossan, Luke Mair, Helena Parsons, Rachel S Tattersall, Kumar K Basu
61 [GO] 2021―Aug―19 Compassionate use of REGN-COV2 in the treatment of COVID-19 in a patient with impaired humoral immunity Hanna Nguyen, Jo Salkeld, Sangita Agarwal, Anna Goodman
62 [GO] 2021―Aug―10 Recombinant Human Plasma Gelsolin (rhu-pGSN) in a Patient Hospitalized with Critical COVID-19 Pneumonia Julie V. Catteeuw, Mark J. DiNubile
63 [GO] 2021―Jul―23 Clinical utility of a rapid ‘on-demand’ laboratory-based SARS-CoV-2 diagnostic testing service in an acute hospital setting admitting COVID-19 patients Fiona Yau, Rosalina Ferreira, Rima Kamali, Paul W Bird, Richard Halliwell, Hemu Patel, et al. (+3)
64 [GO] 2021―Jul―06 A study of staff mask contamination on a respiratory admissions ward managing COVID-19 patients reveals concern with infection prevention practice Ahmed Fouda, Abdulrahman Abouzaid, Joicy David, Christopher W Holmes, Daniela C Nicoara, Gerrit Woltmann, Julian W Tang
65 [GO] 2020―Dez―07 Aortic thrombosis in COVID-19 Helena Wickham, Jerry C.H. Tam, Xin Hui S. Chan, Marc J. George, Marcel Levi, Michael Brown
66 [GO] 2020―Nov―01 Hereditary haemochromatosis, haemophagocytic lymphohistiocytosis and COVID-19 Matthew J. Riley, Scott Rory Hicks, Sharon Irvine, Tom J. Blanchard, Edward Britton, Howida Shawki, et al. (+2)
67 [GO] 2020―Nov―01 COVID-19-associated encephalitis successfully treated with combination therapy Eric Freire-Álvarez, Lucía Guillén, Karine Lambert, Ana Baidez, Miguel García-Quesada, María Andreo, et al. (+3)
68 [GO] 2020―Okt―15 Lymphocyte Count and Partial Pressure of Oxygen can be used as a Screening Test for COVID-19 in Secondary Care Terrence Yin-Hang Chan, Ruben Alexander Van Der Valk, Sandra Danso-Bamfo, Arthur Gywn Remilekun Ogunko
69 [GO] 2020―Okt―14 The COVID-19 cohort ward experience: All hands on deck Seow Yen Tan, Jaime Mei Fong Chien, Jie Li, Eng Kiong Teo, Augustine Tee
70 [GO] 2020―Sep―09 Cold agglutinin syndrome in Covid-19 Christopher E. Jensen, Samuel Wilson, Aparna Thombare, Susan Weiss, Alice Ma
71 [GO] 2020―Jul―02 Troponin I, a risk factor indicating more severe pneumonia among patients with novel coronavirus infected pneumonia Dong Liu, Qingyuan Yang, Wei Chen, Hong Chen, Yun Feng, Weiping Hu, et al. (+4)
72 [GO] 2020―Jun―26 Encephalopathy as neurological involvement of SARS-COV-2 infection MariaRita Lo Monaco, Simona Di Giambenedetto, Anna Maria Martone, Katleen De Gaetano Donati, Francesco Landi
73 [GO] 2020―Mai―24 Hyperinflammation with COVID-19: The key to patient deterioration? Kathryn Haigh, Zoe Joanna Syrimi, Sharon Irvine, Tom J. Blanchard, Muhammad Sajid Pervaiz, Arpad G. Toth, Libuse Ratcliffe
 [1] 

73 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec